A. Lamour

1.4k total citations
31 papers, 642 citations indexed

About

A. Lamour is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, A. Lamour has authored 31 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 12 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Physiology. Recurrent topics in A. Lamour's work include Salivary Gland Disorders and Functions (12 papers), T-cell and B-cell Immunology (12 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). A. Lamour is often cited by papers focused on Salivary Gland Disorders and Functions (12 papers), T-cell and B-cell Immunology (12 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). A. Lamour collaborates with scholars based in France, United Kingdom and Greece. A. Lamour's co-authors include Pierre Youinou, P. Le Goff, Valérie Devauchelle, I Valls, Françis Guillemin, Lorna Mackenzie, Alain Saraux, J. Allain, Jean Jouquan and Christophe Jamin and has published in prestigious journals such as Blood, Clinical & Experimental Immunology and Journal of Autoimmunity.

In The Last Decade

A. Lamour

31 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Lamour France 16 308 257 144 129 118 31 642
Gudrun Steinhauser Germany 6 422 1.4× 188 0.7× 148 1.0× 135 1.0× 43 0.4× 9 645
Bernie Scallon Sweden 5 234 0.8× 200 0.8× 103 0.7× 61 0.5× 125 1.1× 6 639
Aurélie Ambrosi Sweden 13 471 1.5× 339 1.3× 93 0.6× 205 1.6× 172 1.5× 18 862
P Mumford United Kingdom 12 144 0.5× 320 1.2× 204 1.4× 55 0.4× 68 0.6× 24 527
S Fong United States 12 360 1.2× 127 0.5× 342 2.4× 67 0.5× 101 0.9× 14 565
S Ozaki Japan 16 352 1.1× 269 1.0× 120 0.8× 37 0.3× 171 1.4× 30 813
M F Gourley United States 7 477 1.5× 566 2.2× 280 1.9× 70 0.5× 123 1.0× 10 887
Gale A. McCarty United States 13 248 0.8× 410 1.6× 137 1.0× 30 0.2× 93 0.8× 21 725
Haraldine A. Stafford United States 12 327 1.1× 305 1.2× 218 1.5× 36 0.3× 63 0.5× 22 578
Charles Mackworth‐Young United Kingdom 13 279 0.9× 379 1.5× 242 1.7× 36 0.3× 76 0.6× 30 660

Countries citing papers authored by A. Lamour

Since Specialization
Citations

This map shows the geographic impact of A. Lamour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lamour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lamour more than expected).

Fields of papers citing papers by A. Lamour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lamour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lamour. The network helps show where A. Lamour may publish in the future.

Co-authorship network of co-authors of A. Lamour

This figure shows the co-authorship network connecting the top 25 collaborators of A. Lamour. A scholar is included among the top collaborators of A. Lamour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Lamour. A. Lamour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durand, Véronique, A. Lamour, Valérie Devauchelle, Pierre Youinou, & Christophe Jamin. (2000). Fc-Gamma Receptor Reactivity in Nonorgan-Specific Autoimmune Diseases. Clinical Reviews in Allergy & Immunology. 18(1). 11–26. 6 indexed citations
2.
Lamour, A., Rozenn Le Corre, Claude Soubrane, David Khayat, & Pierre Youinou. (1996). Anti-Fc Gamma Receptor Autoantibodies from Patients with Sjögren's Syndrome do Not React with Native Receptor on Human Polymorphonuclear Leukocytes. Journal of Autoimmunity. 9(2). 181–191. 8 indexed citations
3.
Lamour, A., et al.. (1996). Novel enzyme-linked immunosorbent assays for the detection of anti-Fc gamma receptor autoantibodies. Clinical and Diagnostic Laboratory Immunology. 3(3). 315–320. 2 indexed citations
4.
Adler, Yehuda, A. Lamour, Christophe Jamin, et al.. (1995). Impaired binding capacity of asialyl and agalactosyl IgG to Fc gamma receptors.. PubMed. 13(3). 315–9. 18 indexed citations
5.
Lamour, A., et al.. (1995). The presence of anti-Fc gamma receptor autoantibodies is related to the clinical presentation of primary Sjögren's syndrome.. PubMed. 22(12). 2241–5. 9 indexed citations
6.
Lamour, A., et al.. (1995). The majority of FcγRIII-positive γδT cells do not express HLA-DR in patients with primary Sjögren's syndrome. Immunology Letters. 45(3). 153–155. 6 indexed citations
7.
Lamour, A., D. Baron, Claude Soubrane, et al.. (1995). Anti-Fc Gamma Receptor III Autoantibody is Associated with Soluble Receptor in Rheumatoid Arthritis Serum and Synovial Fluid. Journal of Autoimmunity. 8(2). 249–265. 17 indexed citations
8.
Youinou, Pierre, et al.. (1994). Anti-Ro(SSA) and anti-La(SSB) antibodies in autoimmune rheumatic diseases. Clinical Reviews in Allergy. 12(3). 253–274. 9 indexed citations
9.
Smith, et al.. (1994). Selective expression of V beta families by T cells in the blood and salivary gland infiltrate of patients with primary Sjögren's syndrome.. PubMed. 21(10). 1832–7. 17 indexed citations
10.
Lydyard, Peter M., A. Lamour, Lorna Mackenzie, et al.. (1993). CD5+ B cells and the immune system. Immunology Letters. 38(2). 159–166. 17 indexed citations
11.
Lamour, A., et al.. (1993). Prognostic significance of cytotoxic T cells in individuals infected with human immunodeficiency virus. Journal of Clinical Immunology. 13(2). 139–144. 5 indexed citations
12.
Youinou, Pierre, Lorna Mackenzie, A. Lamour, Rizgar A. Mageed, & Peter M. Lydyard. (1993). Human CD5‐positive B Cells in lymphoid malignancy and connective tissue diseases. European Journal of Clinical Investigation. 23(3). 139–150. 32 indexed citations
13.
Jamin, Christophe, A. Lamour, Lorna Mackenzie, et al.. (1992). Cell-free CD5 in patients with rheumatic diseases. Immunology Letters. 31(1). 79–83. 20 indexed citations
14.
Youinou, Pierre, et al.. (1992). Galactose terminating oligosaccharides of IgG in patients with primary Sjögren's syndrome. Journal of Autoimmunity. 5(3). 393–400. 31 indexed citations
15.
Lamour, A., et al.. (1992). Anti-neutrophil cytoplasm antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica.. PubMed. 143(7). 429–32. 8 indexed citations
17.
Blaschek, M, et al.. (1991). Anti-organelle and anti-cytoskeletal autoantibodies in the serum of Epstein-Barr virus-infected patients.. PubMed. 142(5). 343–6. 21 indexed citations
18.
Youinou, Pierre, Lorna Mackenzie, Peter D. Katsikis, et al.. (1990). The relationship between cd5‐expressing b lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives. Arthritis & Rheumatism. 33(3). 339–348. 58 indexed citations
19.
Youinou, Pierre, Y Pennec, M Blaschek, et al.. (1988). Activation of peripheral blood lymphocytes in patients with primary sj�gren's syndrome. Rheumatology International. 8(3). 125–130. 13 indexed citations
20.
Blaschek, M, Y Pennec, P. Le Goff, et al.. (1988). Anti-Golgi Complex Autoantibodies in Patients with Primary Sjögren's Syndrome. Scandinavian Journal of Rheumatology. 17(4). 291–296. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026